Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05628207 · ClinicalTrials.gov registry record

Evaluation of the SCALED (SCaling AcceptabLE cDs)

A clinical trial of Traumatic Brain Injury and Venous Thromboembolism, sponsored by University of Minnesota.

Recruiting
Registry status
15,000
Enrollment target
1
Study location

NCT05628207 is a study of Traumatic Brain Injury and Venous Thromboembolism that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 15,000 participants, above the 190-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (7795% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05628207, a study of Traumatic Brain Injury and Venous Thromboembolism, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
15,000 participants
Enrollment target
1
Study location

Study Summary

This project will adapt a currently deployed Clinical Decision Support (CDS) system to deliver a VTE prevention guideline for adult patients with traumatic brain injury (TBI). We believe this is an ideal PCOR use case given PCORI's continued effort to combat VTE in trauma and our experience previously implementing this guideline. The Our overall goal is to successfully scale, evaluate, and maintain an interoperable TBI CDS across 7 total institutions.

Interventions

  • OTHER Observational
  • OTHER Observational-control

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 15,000 participants
Start Date 2023-05-16
Est. Completion 2026-06-30

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT05628207

The ClinicalTrials.gov registry entry for NCT05628207 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 15,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 190-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (7795% higher). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which Observational is the first listed.

NCT05628207 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05628207 about?

NCT05628207 is a clinical study titled "Evaluation of the SCALED (SCaling AcceptabLE cDs)". This project will adapt a currently deployed Clinical Decision Support (CDS) system to deliver a VTE prevention guideline for adult patients with traumatic brain injury (TBI). We believe this is an ideal PCOR use case given PCORI's continued effort to combat VTE in trauma and our experience previous...

What is the current status of trial NCT05628207?

This trial is currently recruiting. The enrollment target is 15,000 participants. The study started on 2023-05-16. Estimated completion is 2026-06-30.

What conditions does trial NCT05628207 study?

This clinical trial studies the following conditions: Traumatic Brain Injury, Venous Thromboembolism.

What interventions are being tested in trial NCT05628207?

The interventions under investigation include: Observational (OTHER), Observational-control (OTHER).

Who is sponsoring clinical trial NCT05628207?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05628207 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.